Aethlon Medical (AEMD) Equity Ratio (2016 - 2024)
Aethlon Medical (AEMD) has disclosed Equity Ratio for 14 consecutive years, with 0.66 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Equity Ratio fell 8.92% year-over-year to 0.66, compared with a TTM value of 0.66 through Dec 2024, down 8.92%, and an annual FY2024 reading of 0.7, down 18.72% over the prior year.
- Equity Ratio was 0.66 for Q4 2024 at Aethlon Medical, down from 0.68 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.96 in Q3 2021 and bottomed at 0.66 in Q4 2024.
- Average Equity Ratio over 5 years is 0.84, with a median of 0.87 recorded in 2022.
- The sharpest move saw Equity Ratio skyrocketed 5487.09% in 2020, then fell 18.72% in 2024.
- Year by year, Equity Ratio stood at 0.9 in 2020, then grew by 3.95% to 0.94 in 2021, then decreased by 11.12% to 0.83 in 2022, then decreased by 12.53% to 0.73 in 2023, then dropped by 8.92% to 0.66 in 2024.
- Business Quant data shows Equity Ratio for AEMD at 0.66 in Q4 2024, 0.68 in Q3 2024, and 0.76 in Q2 2024.